New research from the American Academy Of Neurology, published today (10 October) in Neurology, has suggested that people living with a type of irregular heartbeat, known as Atrial Fibrillation, are at a greater risk of developing vascular dementia or mixed dementia including vascular dementia.

Half of women will develop dementia, Parkinson's disease or have a stroke in their lifetime, new research suggests.

Scientists say they have found a groundbreaking way to target the toxic particles that cause Alzheimer's disease.

Novartis, Amgen and Banner Alzheimer’s Institute, in association with Alzheimer’s Disease International, today announced results from an online survey investigating perceptions of Alzheimer’s disease.

New research from UCL out tomorrow has highlighted the difference in diagnosis rates between black ethnic groups compared to white groups in the UK.

New research, which brings together the views of the world’s leading experts, has concluded that non-drug approaches should be prioritised in treating agitation in people with Alzheimer’s Disease.

New research has found that ten minutes of social interaction a day helps improve wellbeing for people with dementia in care homes.

New research has found that the cholesterol control drug, Gemfibrozil, reduces levels of amyloid and brain inflammation in mice.

New research shows that a genetic variant of the PLCG2 gene may reduce the risk of developing some dementias and healthy ageing.

New research shows a link between reducing amyloid in the brain and slowing cognitive decline.

New research shows that a study of the immunotherapy treatment Crenezumab has found it can reduce levels of the protein amyloid, associated with dementia.